ESR1 and lung cancer: Interestingly, BEAS-2B cell treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and RSV repressed TCDD-inducible gene transcription in estrogen receptor (ER+) human lung cancer [13].